Stereoselective synthesis of fused tetrahydroquinazolines through one-pot double [3 + 2] dipolar cycloadditions followed by [5 + 1] annulation

  1. 1 ,
  2. 1 ,
  3. 1 ,
  4. 1 ,
  5. 1 ,
  6. 2 and
  7. 1
1Center for Green Chemistry and Department of Chemistry, University of Massachusetts Boston, 100 Morrissey Boulevard, Boston, MA 02125, USA
2Department of Chemistry, Keene State College, 220 Main Street, Keene, NH 03435, USA
  1. Corresponding author email
Guest Editor: L. Vaccaro
Beilstein J. Org. Chem. 2016, 12, 2204–2210. https://doi.org/10.3762/bjoc.12.211
Received 13 Aug 2016, Accepted 29 Sep 2016, Published 18 Oct 2016
Full Research Paper
cc by logo

Abstract

The one-pot [3 + 2] cycloaddition of an azomethine ylide with a maleimide followed by another [3 + 2] cycloaddition of an azide with the second maleimide gives a 1,5-diamino intermediate which is used for a sequential aminomethylation reaction with formaldehyde through [5 + 1] annulation to afford a novel polycyclic scaffold bearing tetrahydroquinazoline, pyrrolidine, pyrrolidinedione, and N-substituted maleimide in stereoselective fashion.

Introduction

The synthesis of new molecules with potential biological activity through pot, atom and step-economic (PASE) reactions is an attractive green organic technique [1-5]. By the combination of multicomponent reactions (MCR) [6-11] with stepwise one-pot reactions [12-17], our lab has introduced a series of synthetic methods for heterocyclic compounds I–VI bearing heterocyclic rings such as hydantoin, pyrrolidine, pyrrolidinedione, piperazinedione, and dihydrobenzodiazepinedione (Scheme 1) [4,18-21]. All these scaffolds were prepared using one-pot intermolecular or intramolecular [3 + 2] azomethine ylide cycloadditions [22-27] as the initial step followed by cyclization or cycloaddition reactions to form polycyclic scaffolds with skeleton, substitution, and stereochemistry diversities. Introduced in this paper is a new sequence initiated with a three-component [3 + 2] cycloaddition for preparing polycyclic scaffold 1 bearing tetrahydroquinazoline, pyrrolidine, pyrrolidinedione, and N-substituted maleimide rings. Those heterocyclic fragments could be found in bioactive compounds such as bromodomain, thrombin, potassium channel, mPGES-1, and tubulin inhibitors, as well as the immunomodulatory drug thalidomide [28-32] (Figure 1).

[1860-5397-12-211-i1]

Scheme 1: Polycyclic scaffolds derived from [3 + 2] adducts 2.

[1860-5397-12-211-1]

Figure 1: Heterocyclic fragments in bioactive compounds.

Results and Discussion

Our initial effort was focused on the development of reaction conditions for the one-pot double [3 + 2] cycloadditions. The first [3 + 2] cycloaddition of azomethine ylide was carried out using glycine methyl ester (3a), 2-azidobenzaldehyde (4a), and N-methylmaleimide (5a) as reactants [33]. After exploring the reactions with different temperatures, times, solvents, and bases, it was found that with a 1.2:1.1:1.0 ratio of 3a:4a:5a, Et3N as a base, and MeCN as a solvent, the three-component reaction for 2a was completed under microwave heating at 115 °C for 25 min. Without work-up, the reaction mixture was directly reacted with 1.0 equiv of N-benzylmaleimide (6a) under microwave heating at 125 °C for 25 min to give 7a as a major diastereomer of a denitrogenation compound in 74% LC yield with a 39:1 dr (Table 1, entry 5). The diastereomer 7a was isolated in 65% yield by preparative chromatography. The stereochemistry of the final product was established during the first [3 + 2] cycloaddition of the azomethine ylide which has been well reported in literature [22-27].

Table 1: One-pot double [3 + 2] cycloaddition for 7aa.

[Graphic 1]
entry T1 (°C) solvent base (2 equiv) T2 (°C) t (min) 7a (%)b dr
1 150 toluene Et3N 150 25 65 40:1
2 125 dioxane Et3N 125 25 33 15:1
3 115 EtOH Et3N 115 25 45 21:1
4 115 CH3CN Et3N 115 25 70 30:1
5 115 CH3CN Et3N 125 25 74 (65)c 39:1
6 115 CH3CN K2CO3 125 25 51 9:1
7 115 CH3CN DBU 125 25 60 29:1
8 115 CH3CN DIPEA 125 25 72 38:1
9 115 CH3CN Et3N 125 10 63 35:1
10 115 CH3CN Et3N 125 50 72 39:1
11 115 CH3CN Et3N 150 25 68 41:1

a1.2:1.1:1.0:1.0 of 3a:4a:5a:6a; bdetected by LC; cisolated yield.

We next explored the reaction scope of the one-pot double [3 + 2] reactions under the optimized conditions by using different sets of building blocks of 3, 4, 5, and 6 to afford analogs 7a–p in 21–73% isolated yields as single diastereomers (Figure 2). Compound 7b was an exception, which was obtained in a trace amount. It was found that replacing maleimides 6 with other activated alkenes such as dimethyl maleate, benzoquinone, naphthalene-1,4-dione, and maleonitrile failed to afford products 7qt, probably due to unfavorable stereoelectronic effects associated with these substrates.

[1860-5397-12-211-2]

Figure 2: One-pot double [3 + 2] cycloadditions and denitrogenation for product 7 under the optimized reaction conditions, see Table 1, entry 5. nd = not detected.

The stereochemistry of 7h has been determined by X-ray single crystal structure analysis (Figure 3). As mentioned previously, the stereoselectivity of the first [3 + 2] cycloaddition for compounds 2 has been well reported [22-27]. The mechanism for the second [3 + 2] cycloaddition of azide compounds 2 with maleimides and sequential denitrogenation to products 7 is proposed in Scheme 2.

[1860-5397-12-211-3]

Figure 3: X-ray structure of 7h.

[1860-5397-12-211-i2]

Scheme 2: Proposed mechanism for the 2nd [3 + 2] cycloaddition and denitrogenation.

1,5-Diamino compounds 7 generated by one-pot reactions are good substrates for [5 + 1] annulation with aldehydes to form tetrahydroquinazolines 1 [34,35]. After exploring the reaction conditions, it was found that the reaction of 7a with formaldehyde in 1,4-dioxane at 110 °C afforded product 1a in 93% isolated yield (Table 2, entry 3). Other reactants such as HC(OEt)3, HCO2H, and paraformaldehyde (PFA) were also employed for the [5 + 1] annulation reactions. But only formaldehyde afforded tetrahydroquinazoline 1a in good yield under catalyst-free conditions. A number of [5 + 1] annulation reactions using selected compounds 7 were carried out to afford 10 analogs of tetrahydroquinazolines 1 in 88–95% isolated yields as single diastereomers (Figure 4). In addition to formaldehyde, other aldehydes could also be used for the [5 + 1] annulation according to literature [34,35].

Table 2: Optimization of [5 + 1] annulation for product 1aa.

[Graphic 2]
entry reactant (equiv) catalyst (equiv) solvent T1 (°C) t (h) 1a (%)a
1 HC(OEt)3 (1.5) NH4Cl (2.0) H2O 100 3 51
2 HCO2H (3.0) H2O 100 5 ndb
3 HCHO (3.0) 1,4-dioxane 110 3 93
4 PFA (2.0) TFA (3.0) 1,4-dioxane 110 4 73

aIsolated yield; bnd = not detected.

[1860-5397-12-211-4]

Figure 4: [5 + 1] Annulation for tetrahydroquinazolines 1.

Conclusion

A one-pot reaction sequence involving [3 + 2] cycloaddition of azomethine ylides, [3 + 2] cycloaddition of azides with alkenes, and denitrogenation followed by a [5 + 1] anulation has been developed for the synthesis of fused-tetrahydroquinazolines as single diastereomers. The formation of triazoles from the second [3 + 2] cycloaddition readily affords denitrogenated 1,5-diamino compounds which are good substrates for aminomethylation with formaldehyde through a [5 + 1] annulation. The final products have a unique polycyclic skeleton containing tetrahydroquinazoline, pyrrolidine, pyrrolidinedione, and N-substituted maleimide ring systems.

Experimental

General Information

Chemicals and solvents were purchased from commercial suppliers and used as received. 1H NMR (300 or 400 MHz) and 13C NMR spectra (75 or 101 MHz) were recorded on Agilent NMR spectrometers. Chemical shifts were reported in parts per million (ppm), and the residual solvent peak was used as an internal reference: proton (chloroform δ 7.26; dioxane δ 3.71; H2O δ 1.56), carbon (chloroform δ 77.0). Multiplicity was indicated as follows: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), dd (doublet of doublet), br s (broad singlet). Coupling constants were reported in hertz (Hz). LC–MS was performed on an Agilent 2100 LC with a 6130 quadrupole MS spectrometer. A C18 column (5.0 μm, 6.0 × 50 mm) was employed for the separation. The mobile phases were MeOH and H2O both of which contained 0.05% CF3CO2H. A linear gradient from 25:75 (v/v) MeOH/water to 100% MeOH over 7.0 min at a flow rate of 0.7 mL/min was employed as a mobile phase. UV detections were conducted at 210 nm, 254 nm and 365 nm. Low resolution mass spectra were recorded with APCI (atmospheric pressure chemical ionization). The final products were purified on Angela HP-100 pre-LC system with a Venusil PrepG C18 column (10 μm, 120 Å, 21.2 mm × 250 mm).

General procedure for the one-pot synthesis of compounds 7

The following procedure is analogous to one of our previous procedures [4]. To a solution of an amino ester 3 (1.2 mmol), 2-azidobenzaldehyde (4, 1.1 mmol), and maleimide 5 (1.0 mmol) in 2.0 mL of CH3CN was added Et3N (2.0 mmol). After being stirred at 25 °C for 5 min, the reaction mixture was heated by microwave irradiation at 115 °C for 25 min. Upon the completion of the reaction as monitored by LC–MS, maleimide 6 (1.0 mmol) was added to the reaction mixture and then heated by microwave irradiation at 125 °C for 25 min. The concentrated reaction mixture was isolated on a semi-preparative HPLC with a C18 column to afford purified product 7 as a single diastereomer.

General procedure for [5 + 1] annulation for the synthesis of products 1

To a solution of compound 7 (0.5 mmol), in 1.0 mL of 1,4-dioxane was added formaldehyde solution (16% in H2O, 1.5 mmol). The reaction mixture was heated at 110 °C for 3 h. Upon the completion of the reaction as monitored by LC–MS, the reaction mixture was concentrated and then isolated on a semi-preparative HPLC with a C18 column to afford purified product 1.

Supporting Information

Supporting Information File 1: Compound characterization data, X-ray report, and copies of NMR spectra.
Format: PDF Size: 1.9 MB Download

References

  1. Clarke, P. A.; Santos, S.; Martin, W. H. C. Green Chem. 2007, 9, 438–440. doi:10.1039/B700923B
    Return to citation in text: [1]
  2. Bhuyan, D.; Sarma, R.; Dommaraju, Y.; Prajapati, D. Green Chem. 2014, 16, 1158–1162. doi:10.1039/C3GC42389A
    Return to citation in text: [1]
  3. Prasanna, P.; Perumal, S.; Menéndez, J. C. Green Chem. 2013, 15, 1292–1299. doi:10.1039/C3GC37128J
    Return to citation in text: [1]
  4. Zhang, X.; Zhi, S.; Wang, W.; Liu, S.; Jasinski, J. P.; Zhang, W. Green Chem. 2016, 18, 2642–2646. doi:10.1039/C6GC00497K
    Return to citation in text: [1] [2] [3]
  5. Weng, J.; Wang, S.; Huang, L.-J.; Luo, Z.-Y.; Lu, G. Chem. Commun. 2015, 51, 10170–10173. doi:10.1039/C5CC01077B
    Return to citation in text: [1]
  6. Cioc, R. C.; Ruijter, E.; Orru, R. V. A. Green Chem. 2014, 16, 2958–2975. doi:10.1039/C4GC00013G
    Return to citation in text: [1]
  7. Rotstein, B. H.; Zaretsky, S.; Rai, V.; Yudin, A. K. Chem. Rev. 2014, 114, 8323–8359. doi:10.1021/cr400615v
    Return to citation in text: [1]
  8. Estévez, V.; Villacampa, M.; Menéndez, J. C. Chem. Soc. Rev. 2014, 43, 4633–4657. doi:10.1039/C3CS60015G
    Return to citation in text: [1]
  9. Dömling, A.; Wang, W.; Wang, K. Chem. Rev. 2012, 112, 3083–3135. doi:10.1021/cr100233r
    Return to citation in text: [1]
  10. Brauch, S.; van Berkel, S. S.; Westermann, B. Chem. Soc. Rev. 2013, 42, 4948–4962. doi:10.1039/C3CS35505E
    Return to citation in text: [1]
  11. Gu, Y. Green Chem. 2012, 14, 2091–2128. doi:10.1039/C2GC35635J
    Return to citation in text: [1]
  12. Anastas, P.; Eghbali, N. Chem. Soc. Rev. 2010, 39, 301–312. doi:10.1039/B918763B
    Return to citation in text: [1]
  13. Nicolaou, K. C.; Chen, J. S. Chem. Soc. Rev. 2009, 38, 2993–3009. doi:10.1039/B903290H
    Return to citation in text: [1]
  14. Nicolaou, K. C.; Edmonds, D. J.; Bulger, P. G. Angew. Chem., Int. Ed. 2006, 45, 7134–7186. doi:10.1002/anie.200601872
    Return to citation in text: [1]
  15. Padwa, A.; Bur, S. K. Tetrahedron 2007, 63, 5341–5378. doi:10.1016/j.tet.2007.03.158
    Return to citation in text: [1]
  16. Enders, D.; Grondal, C.; Hüttl, M. R. M. Angew. Chem., Int. Ed. 2007, 46, 1570–1581. doi:10.1002/anie.200603129
    Return to citation in text: [1]
  17. Wasilke, J.-C.; Obrey, S. J.; Baker, R. T.; Bazan, G. C. Chem. Rev. 2005, 105, 1001–1020. doi:10.1021/cr020018n
    Return to citation in text: [1]
  18. Werner, S.; Nielsen, S. D.; Wipf, P.; Turner, D. M.; Chambers, P. G.; Geib, S. J.; Curran, D. P.; Zhang, W. J. Comb. Chem. 2009, 11, 452–459. doi:10.1021/cc900003q
    Return to citation in text: [1]
  19. Zhang, W.; Lu, Y.; Chen, C. H.-T.; Curran, D. P.; Geib, S. Eur. J. Org. Chem. 2006, 2055–2059. doi:10.1002/ejoc.200600077
    Return to citation in text: [1]
  20. Lu, Q.; Huang, X.; Song, G.; Sun, C.-M.; Jasinski, J. P.; Keeley, A. C.; Zhang, W. ACS Comb. Sci. 2013, 15, 350–355. doi:10.1021/co400026s
    Return to citation in text: [1]
  21. Lu, Q.; Song, G.; Jasinski, J. P.; Keeley, A. C.; Zhang, W. Green Chem. 2012, 14, 3010–3012. doi:10.1039/C2GC36066G
    Return to citation in text: [1]
  22. Hashimoto, T.; Maruoka, K. Chem. Rev. 2015, 115, 5366–5412. doi:10.1021/cr5007182
    Return to citation in text: [1] [2] [3]
  23. Seidel, D. Acc. Chem. Res. 2015, 48, 317–328. doi:10.1021/ar5003768
    Return to citation in text: [1] [2] [3]
  24. Coldham, I.; Hufton, R. Chem. Rev. 2005, 105, 2765–2810. doi:10.1021/cr040004c
    Return to citation in text: [1] [2] [3]
  25. Pellissier, H. Tetrahedron 2007, 63, 3235–3285. doi:10.1016/j.tet.2007.01.009
    Return to citation in text: [1] [2] [3]
  26. Narayan, R.; Potowski, M.; Jia, Z.-J.; Antonchick, A. P.; Waldmann, H. Acc. Chem. Res. 2014, 47, 1296–1310. doi:10.1021/ar400286b
    Return to citation in text: [1] [2] [3]
  27. Zhang, W. Chem. Lett. 2013, 42, 676–681. doi:10.1246/cl.130504
    Return to citation in text: [1] [2] [3]
  28. Marineau, J. J.; Bradner, J. E.; Zhang, W.; Qi, J.; Mckeown, M. R.; Fu, H.; Liu, S. Inhibitors of transcription factors and uses thereof. WO Patent WO013635 A2, Jan 29, 2015.
    Return to citation in text: [1]
  29. Olsen, J.; Seiler, P.; Wagner, B.; Fischer, H.; Tschopp, T.; Obst-Sander, U.; Banner, D. W.; Kansy, M.; Müller, K.; Diederich, F. Org. Biomol. Chem. 2004, 2, 1339–1352. doi:10.1039/B402515F
    Return to citation in text: [1]
  30. Trotter, B. W.; Isaacs, R. Quinazoline potassium channel inhibitors. WO Patent WO030217 A1, April 7, 2015.
    Return to citation in text: [1]
  31. Rörsch, F.; la Buscató, E.; Deckmann, K.; Schneider, G.; Schubert-Zsilavecz, M.; Geisslinger, G.; Proschak, E.; Grösch, S. J. Med. Chem. 2012, 55, 3792–3803. doi:10.1021/jm201687d
    Return to citation in text: [1]
  32. Rashid, A.; Kuppa, A.; Kunwar, A.; Panda, D. Biochemistry 2015, 54, 2149–2159. doi:10.1021/bi501429j
    Return to citation in text: [1]
  33. Zhang, W.; Lu, Y.; Geib, S. Org. Lett. 2005, 7, 2269–2272. doi:10.1021/ol0507773
    Return to citation in text: [1]
  34. Korshin, E. E.; Sabirova, L. A.; Levinb, Y. A. Synthesis 2012, 44, 3512–3522. doi:10.1055/s-0032-1316802
    Return to citation in text: [1] [2]
  35. Göblyös, A.; Lázár, L.; Fülöp, F. Tetrahedron 2002, 58, 1011–1016. doi:10.1016/S0040-4020(01)01196-6
    Return to citation in text: [1] [2]
Other Beilstein-Institut Open Science Activities